Orise
Device Orise_Endo
PDI 08714729974604
General payments
$586,847
Research payments
$0
Through program year 2025, $586,847 in general payments and $0 in research payments were reported against Orise (Orise_Endo).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $190,418 | 434 |
| 2024 | General | $110,609 | 491 |
| 2023 | General | $108,510 | 449 |
| 2022 | General | $177,310 | 824 |
Breakdown
The top 5 of 94 recipients; each share is of general payments naming this product in 2025.
The top 5 of 12 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 31 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
2,198 generalEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.